Understanding the Treatment Paradigm for Idiopathic Pulmonary Fibrosis: A Guide for the Specialty Pharmacist
This live activity will review additional actions the specialty pharmacist can take to contribute to the care of patients with IPF.
Overview of COVID-19: Evolving Investigational Treatment Landscape and Emerging Data
This activity will provide pharmacists with a quick introduction to COVID-19, with an emphasis on recent data that are emerging on therapeutic options for the management of patients with COVID-19, as well as a brief discussion of vaccine development.
Exploring Cystic Fibrosis Management and Healthcare Economics Associated With Disease Progression
This activity will examine the pathophysiology of cystic fibrosis and the complications associated with disease progression.
Idiopathic Pulmonary Fibrosis: The Specialty Pharmacist's Role in Patient Care and Population Management
Through this activity, specialty pharmacists will become familiar with the current IPF treatment paradigm and receive practice pearls for improving patient care and outcomes.